Application

18347815 · POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF

Filed 2023-07-06 · Granted The official file ↗ · Art unit 1625 · Examiner Nizal S Chandrakumar Typical · CPC A61K 31/4439 · KALVISTA PHARMACEUTICALS LIMITED · STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

Office actions

first was Restriction requirement

RCEs

appealed

To first action

15.6 mo

to disposition 36.8 mo

Statutes raised

112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.